# Serine and Fenofibrate Study in Patients With MacTel Type 2

> **NCT04907084** · PHASE2 · UNKNOWN · sponsor: **The Lowy Medical Research Institute Limited** · enrollment: 60 (estimated)

## Conditions studied

- Macular Telangiectasia Type 2

## Interventions

- **DIETARY_SUPPLEMENT:** Serine
- **DRUG:** Fenofibrate

## Key facts

- **NCT ID:** NCT04907084
- **Lead sponsor:** The Lowy Medical Research Institute Limited
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-07
- **Primary completion:** 2024-03
- **Final completion:** 2024-03
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04907084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04907084, "Serine and Fenofibrate Study in Patients With MacTel Type 2". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04907084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*